Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.35 USD | -0.19% | -3.71% | -32.27% |
May. 14 | Transcript : Syros Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | Syros Pharmaceuticals, Inc. Agrees to Amend Its Loan Agreement with Oxford Finance LLC | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.27% | 143M | |
+59.89% | 62.59B | |
-2.96% | 41.18B | |
+44.53% | 40.29B | |
-8.29% | 27.9B | |
+12.49% | 26.21B | |
-21.73% | 19.09B | |
+5.88% | 13.08B | |
+24.50% | 12.26B | |
+27.44% | 12.05B |
- Stock Market
- Equities
- SYRS Stock
- News Syros Pharmaceuticals, Inc.
- Syros Pharmaceuticals, Inc. Announces Management Changes